BDNF-producing, amyloid β-specific CD4 T cells as targeted drug-delivery vehicles in Alzheimer's disease
Authors:
Open Access
- 1 May 2019
- journal article
- research article
- Published by Elsevier in EBioMedicine
- Vol. 43, 424-434
Abstract
No abstract availableKeywords
Funding Information
- Israel Science Foundation
This publication has 76 references indexed in Scilit:
- 7,8-Dihydroxyflavone, a Small-Molecule TrkB Agonist, Reverses Memory Deficits and BACE1 Elevation in a Mouse Model of Alzheimer's DiseaseNeuropsychopharmacology, 2011
- Postsynaptic degeneration as revealed by PSD-95 reduction occurs after advanced Aβ and tau pathology in transgenic mouse models of Alzheimer’s diseaseActa Neuropathologica, 2011
- Microarray Analysis of Hippocampal CA1 Neurons Implicates Early Endosomal Dysfunction During Alzheimer's Disease ProgressionBiological Psychiatry, 2010
- Macrophage-mediated GDNF Delivery Protects Against Dopaminergic Neurodegeneration: A Therapeutic Strategy for Parkinson's DiseaseMolecular Therapy, 2010
- Synapse loss in dementiasJournal of Neuroscience Research, 2010
- Genetic reductions of β‐site amyloid precursor protein‐cleaving enzyme 1 and amyloid‐β ameliorate impairment of conditioned taste aversion memory in 5XFAD Alzheimer’s disease model miceEuropean Journal of Neuroscience, 2009
- Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer diseaseProceedings of the National Academy of Sciences, 2009
- Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's diseaseNature Medicine, 2009
- Brain-derived Neurotrophic Factor-Tropomyosin-related Kinase B Signaling Contributes to Activity-dependent Changes in Synaptic ProteinsJournal of Biological Chemistry, 2008
- BACE1 gene deletion prevents neuron loss and memory deficits in 5XFAD APP/PS1 transgenic miceNeurobiology of Disease, 2007